Skip to main content

Table 2 Sensitivity analysis – reductions in mortality by 1 % per year for specified cancers

From: Projecting productivity losses for cancer-related mortality 2011 – 2030

Cancer

Projected number of deaths

Value of lost paid production (million €)

Value of lost household production (million €)

Projected number of deaths (% of base case)

Value of lost paid production (million €)

Value of lost household production (million €)

 

Base case

1 % Annual reduction in mortality

C18-C21: colorectal

27,631

1321

6567

23,344 (84 %)

1169

5765

C25: pancreas

13,488

733

3355

11,673 (87 %)

649

2947

C34: lung

48,922

2403

12,493

41,730 (85 %)

2124

10,970

C50: breast

18,308

1255

7194

15,430 (84 %)

1113

6338

C70-C72: brain & CNS

6513

886

2164

5265 (81 %)

786

1907

C91-C95: leukaemia

6693

454

1691

5096 (76 %)

402

1486

C00-C96: all invasive

233,168

12,685

60,427

206,336 (89 %)

11,231

53,086